Therapeutic Asset Ratings

3,171 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Allorx Polycystic Ovary Syndrome	The Foundation for Orthopaedics and Regenerative Medicine	P1	CC (43)
Amg 553 Acute Myeloid Leukemia	Amgen	P1	CC (43)
Anti-Cd123 Car Nk Cells Acute Myeloid Leukemia	Chongqing Precision Biotech Co., Ltd	P1	CC (43)
Anti-Cd123 Car Nk Cells CD4+/CD56+ Hematodermic Neoplasm	Chongqing Precision Biotech Co., Ltd	P1	CC (43)
Anti-Cd19-Car Cmv-Specific T-Lymphocytes High Grade B-Cell Lymphoma	City of Hope Medical Center	P1	CC (43)
Anti-Cd19-Car Cmv-Specific T-Lymphocytes Non-Hodgkin Lymphoma	City of Hope Medical Center	P1	CC (43)
Anti-Cd19 Car-Nk Cells Primary Central Nervous System Lymphoma	Second Affiliated Hospital, School of Medicine, Zhejiang University	P1	CC (43)
Anti-Cd19 Il10/Il15 Car-Nk B-Cell Non-Hodgkin Lymphoma	Second Affiliated Hospital, School of Medicine, Zhejiang University	P1	CC (43)
Anti-Cd30 Bispecific Antibody-Armed Anti-Cd3-Activated Autologous T-Cells Anaplastic Large Cell Lymphoma	Medical College of Wisconsin	P1	CC (43)
Anti-Cd30 Bispecific Antibody-Armed Anti-Cd3-Activated Autologous T-Cells Primary Cutaneous CD30+ T-Cell Lymphoproliferative Disease	Medical College of Wisconsin	P1	CC (43)
Anti-Cd30 Bispecific Antibody-Armed Anti-Cd3-Activated Autologous T-Cells Primary Cutaneous Anaplastic Large Cell Lymphoma	Medical College of Wisconsin	P1	CC (43)
Anti-Cd30 Bispecific Antibody-Armed Anti-Cd3-Activated Autologous T-Cells Diffuse Large B-Cell Lymphoma	Medical College of Wisconsin	P1	CC (43)
Anti-Cd30 Bispecific Antibody-Armed Anti-Cd3-Activated Autologous T-Cells Hodgkins Lymphoma	Medical College of Wisconsin	P1	CC (43)
Anti-Cd33 Car T-Cells Hematopoietic And Lymphoid Cell Neoplasm	iCell Gene Therapeutics	P1	CC (43)
Anti-Cd5 Car Nk Cells T Lymphoblastic Leukemia/Lymphoma	Chongqing Precision Biotech Co., Ltd	P1	CC (43)
Anti-Cea Car-T Cells Liver Cancer	Changhai Hospital	P1	CC (43)
Anti-Cll-1 Car Nk Cells Acute Myeloid Leukemia	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine	P1	CC (43)
Anti-Flt3 Car-T Cells Acute Myeloid Leukemia	Hemogenyx Pharmaceuticals LLC	P1	CC (43)
Antigen-Specific Igt Cells Brain Glioblastoma	Shenzhen Geno-Immune Medical Institute	P1	CC (43)
Anti-Lilra6 Car-T Cells Acute Myeloid Leukemia	Second Affiliated Hospital, School of Medicine, Zhejiang University	P1	CC (43)
Arm 1: Il13Ra2-Specific Car Tcm Cells Malignant Glioma	City of Hope Medical Center	P1	CC (43)
Arm 1: Il13Ra2-Specific Car Tcm Cells Grade II Glioma	City of Hope Medical Center	P1	CC (43)
Arm 1: Il13Ra2-Specific Car Tcm Cells Grade III Glioma	City of Hope Medical Center	P1	CC (43)
Arm 2: Il13Ra2-Specific Car Tcm Cells Malignant Glioma	City of Hope Medical Center	P1	CC (43)
Arm 2: Il13Ra2-Specific Car Tcm Cells Grade II Glioma	City of Hope Medical Center	P1	CC (43)

Showing 1026 to 1050 of 3,171 assets

PreviousPage 42 of 127Next